Specialties

Type 2 diabetes is a growing health concern among older adults, with an estimated 29 million individuals over the age of 65 in the United States alone being diagnosed with the condition. While type 2 diabetes can affect people of all ages, it is particularly prevalent among older adults due …

Sponsored Content  Bromocriptine-QR (Cycloset) “is a sympatholytic dopamine D2 agonist for the treatment of type 2 diabetes that has demonstrated rapid (within 1 year) substantial reductions in adverse cardiovascular events in this population by as yet incompletely delineated mechanisms.” This study investigated the impact of Cycloset on the pro-inflammatory state …

Young age at diagnosis or disease aggression which increases lifetime risk of CKD in type 2 patients with diabetes Type 2 Diabetes, once considered a disease that comes about at an older age, is now increasingly diagnosed in younger adults. The number of people between the ages of 20-39 years …

Finerenone, a selective nonsteroidal mineralocorticoid receptor antagonist, improves cardiovascular events (MI, stroke, HF) in Type 2 Diabetes and Chronic Kidney Disease (CKD) patients.  Some risk factors for cardiovascular diseases (CVD), such as high blood glucose, blood pressure, serum cholesterol, and BMI, are also associated with CKD and type 2 diabetes. …

A new treatment is on its way providing superior results for the patients suffering from diabetic foot ulcers. Chronic diabetic foot ulcers (DFUs) account for around 80% of lower limb amputations, resulting in effective medical treatment and cost burdens. Currently, the treatment for DFUs concentrates mainly on local wound care, …

Patients with diabetes are likely to be affected by Diabetic foot ulcers (DFUs). This type of disease is popular and enfeeble, generating a surge of serious morbidity and mortality combined with worldwide socio-economic problems. The symptoms of this disease such as infection and inflammation raise surrounding oedema of the foot. …

Is there a link between patients living with sickle cell disease and diabetes mellitus? African-Americans/ Black are the most affected by sickle cell disease (SCD). According to the US Department of Health and Human Services Office of Minority Health, this population also has the highest prevalence of obesity. Sickle cell …

Sodium-glucose cotransporter 2 inhibitors lower the risk of hospitalization in heart failure and cardiovascular death…  The SIMPLE trial examined the effects of empagliflozin on myocardial flow reserve, showing microvascular perfusion in individuals with type 2 diabetes with high CVD risk. The SIMPLE trial is a single-center, double-blind, randomized clinical trial …

Allison S. Rembert, PharmD Candidate 2024 Adrian K. Baker, PharmD Candidate 2024 Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP Department of Pharmacotherapy College of Pharmacy and Pharmaceutical Sciences Washington State University A 55-year-old female with type 2 diabetes (T2D) and chronic kidney disease (CKD) presented to the ambulatory care clinic. …

Controlling your blood sugar is more important than you think in the ICU… Glycemic control for patients is considered one of the most important factors when treating patients in an intensive care unit. Hyperglycemia statistically is deemed to be related to increased mortality and or morbidity. It is also an …